Table I.

Median survival times (MSTs) for each cohort of each experiment.

Group	MST	p-Value*
Concurrent (experiment 1)
1 (Ara-C; n =5)	19	<0.05
2 (Combotox; n =5)	20
3 (Ara-C and Combotox; n =5)	27
4 (normal saline; n =5)	17
Sequential (experiment 2)
1 (Ara-C; n =5)	20	<0.05†
2 (Combotox; n =5)	18
3 (Ara-C and Combotox; n =5)	28
4 (normal saline; n =5)	19
Concurrent vs. sequential (experiment 3)
1 (Ara-C and Combotox concurrent; n =8)	22	<0.001
2 (Ara-C and Combotox sequential; n =8)	36
3 (normal saline; n =8)	28

^*p-Value calculated for overall survival difference with two-sided log-rank test.

^†p-Value for survival analysis calculated excluding mice that died accidentally on day of facial vein blood draw (two per group). If these mice were included, p-value would be 0.13.